Astrocytic adrenergic α2 receptor contributes to the mechanisms underlying the circadian rhythmicity of seizure susceptibility

ACTA PHARMACOLOGICA SINICA · Published 2026-05-27 · DOI 10.1038/s41401-026-01833-6

Free full text

Authors (7)

Cong Wang, Ping-chuan Yuan, Qian Sun, Michael Lazarus, Wei-min Qu, Zhi-li Huang, Feng-fei Ding

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Wang, C., Yuan, P., Sun, Q., et al. (2026). Astrocytic adrenergic α2 receptor contributes to the mechanisms underlying the circadian rhythmicity of seizure susceptibility. ACTA PHARMACOLOGICA SINICA. https://doi.org/10.1038/s41401-026-01833-6

Related articles

• Adenosine receptor signaling in vascular diseases: from molecular mechanisms to targeted therapeutics · ACTA PHARMACOLOGICA SINICA · 2026 · Same journal
• Macrophage FOLR2 drives liver fibrosis via intercellular engagement of TGFβRII · ACTA PHARMACOLOGICA SINICA · 2026 · Same journal
• Cardiomyocyte OTUD7b drives diabetic cardiomyopathy via deubiquitinating and stabilizing TAK1 · ACTA PHARMACOLOGICA SINICA · 2026 · Same journal
• The solute carrier transporter SLCO5A1 as a novel therapeutic target for the treatment of myocardial infarction-induced heart failure · ACTA PHARMACOLOGICA SINICA · 2026 · Same journal
• Serum/glucocorticoid-regulated kinase 1 regulates vascular inflammation in atherosclerosis · ACTA PHARMACOLOGICA SINICA · 2026 · Same journal
• METTL3 loss exacerbates colitis via m6A-dependent Slc39a8 regulation and epithelial lineage depletion · ACTA PHARMACOLOGICA SINICA · 2026 · Same journal
• Secreted chimeric proteins as a strategy to correct SOX17 deficiency and attenuate the malignant phenotype of cholangiocarcinoma cells: a proof-of-concept study · ACTA PHARMACOLOGICA SINICA · 2026 · Same journal
• Activation of peripheral muscarinic receptors rescues depressive-like behaviors via gut-brain-axis, involving parasympathetic excitation · ACTA PHARMACOLOGICA SINICA · 2026 · Same journal
• Molecular mechanisms for sustaining cancer stem cells characteristics and targeted therapeutic strategies · ACTA PHARMACOLOGICA SINICA · 2026 · Same journal
• Structural basis for dual targeting of μ-opioid and nociceptin/orphanin FQ receptors by Cebranopadol · ACTA PHARMACOLOGICA SINICA · 2026 · Same journal